Baxter Recalls One Lot of 70% Dextrose Injection Over Stainless Steel Particulate Risk
Baxter International announced a voluntary recall of a single lot of its 70% Dextrose Injection after detecting potential stainless steel particles in the solution.
The presence of these particles could lead to serious adverse health consequences, including blood vessel blockage, pulmonary embolism, organ damage, or death, as well as local vein irritation and allergic reactions.
As of the August 25, 2026 announcement, Baxter reported no adverse events linked to the issue.
The recalled product is used to provide calories and fluid replenishment when mixed with amino acids or compatible intravenous fluids for patients requiring IV therapy.
This writeup was produced by pharmadog from original reporting by fda medwatch.
Original headline: “Baxter Issues Voluntary Nationwide Recall for One Lot of 70% Dextrose Injection Due to Potential Presence of Particulate Matter”
read at fda medwatch ↗
comments(0)
5-min edit window · permanent after that